Synovics Pharmaceuticals, Inc. (SYVC)

Market Cap	3.65K -99.8%
Revenue (ttm)	19.09M -18.5%
Net Income	-5.04M
EPS	-0.18
Shares Out	36.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,929
Open	0.0001
Previous Close	0.000001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	85.42
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Synovics Pharmaceuticals

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its nam...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 155
• Stock Exchange: OTCMKTS
• Ticker Symbol: SYVC

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 28, 2026

Data Sources Report a data error